| Bharat Biotech in Rs 70 crore capacity expansion | 28-OCT-09 |
|
| Bharat Biotech International (BBI), a city-based manufacturer of vaccines and biotherapeutics, has embarked on a Rs 70-crore capacity expansion plan to meet the growing demand for its anti-rabies vaccine, Indirab. |
|
|
|
| Bharat Biotech's 'INDIRAB' vaccine sales doubles | 27-OCT-09 |
|
| Bharat Biotech, a leading manufacturer of vaccines and biotherapeutics, expects its Anti-Rabies vaccine INDIRAB to more than double its sales within the next two years as sales crossed the one crore doses sales mark. |
|
|
|
| Konark Knowledge Park to have biotech incubation centre | 26-OCT-09 |
|
| The Konark Knowledge Park, a Rs 100-crore biotech-pharma-IT park being developed by Hyderabad-based Bharat Biotech International Limited on around 65 acres of land at Andharua on the outskirts of the city, would have a Biotechnology Incubation Centre spread over 10 acres. |
|
|
|
| Bharat Biotech secures patent for Lysostaphin | 02-OCT-09 |
|
| Hyderabad-based vaccines and biotherapeutics manufacturer Bharat Biotech International said on Wednesday that its anti-staphylococcal molecule Lysostaphin had secured patent rights in US, Europe, China, Australia and other nations. |
|
|
|
| Bharat Biotech gets patent for Lysostaphin | 30-SEP-09 |
|
| Hyderabad-based vaccines and biotherapeutics manufacturer Bharat Biotech International announced on Wednesday that its anti-staphylococcal molecule Lysostaphin had secured patent rights in US, Europe, China, Australia and other nations. |
|
|
|
| Bharat Biotech to test swine flu vaccine in 2 months | 28-SEP-09 |
|
| Hyderabad-based vaccines and biotherapeutics manufacturer Bharat Biotech, which is getting ready with an indigenous H1N1 swine flu candidate vaccine, would go for clinical trials in two months, according to its chairman and managing director Krishna M Ella. |
|
|
|
|
|
|
| Bharat Bio launches first indigenous single-shot against 5 diseases | 02-MAR-09 |
|
| Bharat Biotech International Limited, a Hyderabad-based manufacturer of vaccines and biotherapeutics, on Monday launched COMVAC5, a single-shot pentavalent combination vaccine which contains the first indigenously developed and manufactured haemophilus influenza type-b (Hib) vaccine in India and the only Hepatitis B vaccine in the world to be manufactured without the use of cesium chloride. |
|
|
|
| Orissa set to get biotech pharma IT park | 31-OCT-08 |
|
| Bharat Biotech International Ltd, a Hyderabad-based manufacturer of vaccines and biotherapeutics, has been selected by the Orissa government to set up the state’s first |
|
|
|
|
|
|
| Saamya banks on recombinant protein products | 24-SEP-07 |
|
| Hyderabad-based Saamya Biotech (India) Ltd, a first generation biotech company and backed by the Visu International Group, might enter the manufacture of recombinant protein products by 2010.
|
|
|
|
| Bharat Biotech ties up with Belgium firm | 08-DEC-06 |
|
| ThromboGenics NV of Belgium, a biotechnology company focused on vascular disease, entered into a licence agreement with the Hyderabad-based Bharat Biotech International Limited (BBIL) for |
|
|
|
| Novavax, Bharat Bio to develop anti-bird flu vaccine | 07-MAR-06 |
|
| Close on the heels of Hetero Drugs launching Oseltamivir, an anti-bird flu drug, Nasdaq-listed Novavax Inc and Hyderabad-based Bharat Biotech International today announced a strategic partnership to |
|
|
|
| Bharat Biotech develops rotavirus vaccines | 17-FEB-06 |
|
| The Indian Rotavirus Vaccine Development Project (RVDP), met with encouraging results from a recent Phase I clinical trial of two live, natural reassortant, candidate rotavirus vaccines, 116E and I321 |
|
|
|
| Bharat Bio to set up unit in Malaysia | 09-JAN-06 |
|
| Bharat Biotech will set up a biotechnology facility in Perak, Malaysia, jointly with Perak State Development Corporation and Remco Engineering & Consultancy.
|
|
|
|
Content Guide
